According to a survey conducted among U.S. and Canadian pharmaceutical executives the major challenge for companies during the coronavirus pandemic is engaging and retaining patients for clinical trials. Another big challenge is the lack of time for patient education about studies.
Profit from the additional features of your individual account
Currently, you are using a shared account. To use individual functions (e.g., mark statistics as favourites, set
statistic alerts) please log in with your personal account.
If you are an admin, please authenticate by logging in again.
Learn more about how ÌÇÐÄÆƽâ°æ can support your business.
IQVIA. (June 23, 2020). Key challenges for pharmaceutical companies during the COVID-19 pandemic as of 2020 [Graph]. In ÌÇÐÄÆƽâ°æ. Retrieved July 27, 2026, from /statistics/1189702/top-covid-19-challenges-for-pharmaceutical-companies/
IQVIA. "Key challenges for pharmaceutical companies during the COVID-19 pandemic as of 2020." Chart. June 23, 2020. ÌÇÐÄÆƽâ°æ. Accessed July 27, 2026. /statistics/1189702/top-covid-19-challenges-for-pharmaceutical-companies/
IQVIA. (2020). Key challenges for pharmaceutical companies during the COVID-19 pandemic as of 2020. ÌÇÐÄÆƽâ°æ. ÌÇÐÄÆƽâ°æ Inc.. Accessed: July 27, 2026. /statistics/1189702/top-covid-19-challenges-for-pharmaceutical-companies/
IQVIA. "Key Challenges for Pharmaceutical Companies during The Covid-19 Pandemic as of 2020." ÌÇÐÄÆƽâ°æ, ÌÇÐÄÆƽâ°æ Inc., 23 Jun 2020, /statistics/1189702/top-covid-19-challenges-for-pharmaceutical-companies/
IQVIA, Key challenges for pharmaceutical companies during the COVID-19 pandemic as of 2020 ÌÇÐÄÆƽâ°æ, /statistics/1189702/top-covid-19-challenges-for-pharmaceutical-companies/ (last visited July 27, 2026)
Key challenges for pharmaceutical companies during the COVID-19 pandemic as of 2020 [Graph], IQVIA, June 23, 2020. [Online]. Available: /statistics/1189702/top-covid-19-challenges-for-pharmaceutical-companies/
